Home / People / Carl Leermakers
Portrait of Carl Leermakers

Carl Leermakers

Partner

CMS DeBacker
Chaussée de La Hulpe 178
1170 Brussels
Belgium
Languages Dutch, French, English

Carl Leermakers specializes in mergers and acquisitions and corporate transactional work, inter alia in the energy and ICT sectors. With more than thirty years of experience in M&A within CMS Belgium, his expertise ranges from advising on international corporate structures, over assisting clients in negotiating acquisitions, public offerings and take-over bids, to setting up leveraged buy-outs and exit strategies, tailoring W&I insurances and assessing and negotiating compliance with regulatory requirements. He also conducts litigation related to acquisitions, mostly claims on representations and warranties, including W&I insurance claims. 

more less

Relevant experience

  • Advising the purchaser in a public takeover bid of a large Belgian banking and insurance company
  • IPO, Europe-wide, of financial instruments representing investments in ‘green energy’
  • Restructuring and refinancing (through tolling and securitisation) for the Belgian operations of an international group, (Legal 500 – 2008)
  • Advising international insurers on representations and warranties insurances linked to acquisitions in Belgium
  • Claims management for international insurers on around 60% of all claims involving, since 2007, more than 100 million EUR exposure for insurers in Belgium
  • Cross-border mergers of Belgian and EU banks and insurance companies
more less

Memberships & Roles

  • Head of the firm’s Energy & Climate Change practice
more less

Education

  • 1989 - Katholieke Universiteit Leuven, KUL (Law Degree)
  • 1990 - Katholieke Universiteit Leuven, KUL (Postgraduate degree in Notarial Law)
  • 1990 - Bar admission (Brussels, Belgium)
more less

Feed

29/09/2022
Boom & Gloom? CMS European M&A Out­look 2023
We are pleased to share with you the 2023 edi­tion of the European M&A Out­look pub­lished by CMS in as­so­ci­ation with Mer­ger­mar­ket.
22/09/2022
Deal­makers bullish des­pite chal­len­ging mar­ket con­di­tions
M&A ex­pect­a­tions run high: Al­most all re­spond­ents (88%) are cur­rently con­sid­er­ing M&A.Un­der­val­ued tar­gets and dis­tressed sales to drive activ­ity: The biggest buy-side driver of M&A is ex­pec­ted to be the...
23/03/2022
CMS: European M&A bounced back to pre-pan­dem­ic levels, with a re­turn to...
Multi-year ana­lys­is by CMS re­veals that ‘nor­mal ser­vice’ had re­sumed in European deal­mak­ing as fa­mil­i­ar pat­terns in deal met­rics re­turnPrimary deal driver for trans­ac­tions is buy­ers en­ter­ing a new...
14/09/2021
The Road to Re­cov­ery: European M&A Out­look 2022
71% of deal­makers agree that private equity (PE) firms are bet­ter placed than cor­por­ates to take ad­vant­age of buy­ing op­por­tun­it­ies presen­ted by COV­ID-19, ac­cord­ing to the ninth edi­tion of the European...
24/03/2021
CMS European M&A Study 2021: Europe pivots to be­come more ‘buy­er-friendly’...
Europe has re­turned to a ‘buy­er-friendly’ en­vir­on­ment, sim­il­ar to the US where more ‘buy­er-friendly’ po­s­i­tions are com­mon, after the COV­ID-19 pan­dem­ic cre­ated more risk-averse at­ti­tudes. As a...
07/12/2020
CMS Bel­gi­um as­sisted Prox­imus in es­tab­lish­ing a part­ner­ship with EQT In­fra­struc­ture...
CMS Bel­gi­um as­sisted Tele­com op­er­at­or Prox­imus in con­nec­tion with the es­tab­lish­ment of a part­ner­ship with EQT In­fra­struc­ture (through its port­fo­lio com­pany DELTA Fiber) for build­ing a fibre net­work to­geth­er...
22/09/2020
Who dares wins: European M&A Out­look 2020
The COV­ID-19 pan­dem­ic has taken a heavy toll on European deal­mak­ing activ­ity. However, op­por­tun­it­ies re­main for those will­ing to take risks, ac­cord­ing to the eighth edi­tion of the European M&A Out­look...
10/04/2020
Im­pact of the Coronavir­us on the or­gan­iz­a­tion of an­nu­al gen­er­al meet­ings...
Bel­gian au­thor­it­ies, like some of their European coun­ter­parts, have taken ex­treme meas­ures to fight the spread of Cov­id-19, in­clud­ing re­stric­tions on so­cial gath­er­ings. If these strong meas­ures con­tin­ue...
05/12/2019
CMS re­cog­nised for out­stand­ing M&A ad­vis­ory work
CMS has been re­cog­nised by Mer­ger­mar­ket for its out­stand­ing M&A ad­vis­ory work for deals in the value range of EUR 30m-EUR 1bn. Oth­er nom­in­ees in this cat­egory – “European Mid-Mar­ket M&A Leg­al Ad­viser...
05/09/2019
European M&A ex­ec­ut­ives cau­tious over deal­mak­ing pro­spects
Brus­sels, 5 Septem­ber 2019. Weak eco­nom­ic in­dic­at­ors, un­cer­tainty sur­round­ing Brexit and grow­ing pro­tec­tion­ism in glob­al trade have con­trib­uted to a shift in sen­ti­ment in the M&A com­munity and the be­gin­ning...
30/01/2019
CMS Bel­gi­um as­sisted Guard­Square and its share­hold­ers with an in­vest­ment...
CMS Bel­gi­um as­sisted Guard­Square, a fast-grow­ing and mar­ket-lead­ing Bel­gian tech­start-up that provides mo­bile ap­plic­a­tion pro­tec­tion soft­ware, and its share­hold­ers with an im­port­ant in­vest­ment by Bat­tery...
10/01/2019
CMS Bel­gi­um as­sisted Or­aS­ure Tech­no­lo­gies in the ac­quis­i­tion of Nov­osanis...
CMS Bel­gi­um as­sisted Or­aS­ure Tech­no­lo­gies, a US com­pany lis­ted on NAS­DAQ and a lead­er in the med­ic­al device in­dustry, in con­nec­tion with its ac­quis­i­tion of Nov­osanis NV, a Bel­gian com­pany act­ive in the...